eritropoetinterápiát
Eritropoetinterápia, often referred to as EPO therapy, is a medical treatment that involves the administration of erythropoietin, a hormone produced by the kidneys. Erythropoietin stimulates the bone marrow to produce red blood cells. This therapy is primarily used to treat anemia, a condition characterized by a deficiency of red blood cells or hemoglobin, which leads to reduced oxygen transport in the body.
The most common indication for eritropoetinterápia is anemia associated with chronic kidney disease (CKD). Patients with
Eritropoetinterápia is also utilized in other medical conditions. It can be prescribed for anemia in patients
The administration of eritropoetinterápia is typically done through subcutaneous injections or intravenous infusions. The dosage and